Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000607024 | SCV000728729 | benign | not specified | 2017-02-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000607024 | SCV001362579 | benign | not specified | 2019-09-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001253833 | SCV001429707 | benign | not provided | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001253833 | SCV001746437 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | LZTR1: BP4, BP7 |
Institute for Clinical Genetics, |
RCV001253833 | SCV002009539 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001813527 | SCV002060530 | benign | Noonan syndrome and Noonan-related syndrome | 2020-11-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002404694 | SCV002709699 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2020-08-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001253833 | SCV001807718 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001253833 | SCV001964414 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000607024 | SCV002034306 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004533249 | SCV004737608 | benign | LZTR1-related disorder | 2021-10-29 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |